<DOC>
	<DOCNO>NCT00206024</DOCNO>
	<brief_summary>This multi-center , double-blind , parallel-group , randomize , proof concept trial investigate relationship dose esomeprazole magnesium acid-associated heartburn symptom 4 week treatment . The safety tolerability esomeprazole magnesium dose 40 mg BID also assess .</brief_summary>
	<brief_title>Acid-Associated Heartburn Symptoms Dose Esomeprazole</brief_title>
	<detailed_description />
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Males nonlactating female , age 18 75 year , inclusive , ability understand English provide write informed consent A history heartburn least 6 month A history prior positive relief heartburn symptom antacid acid suppressive therapy A positive esophageal acid perfusion test At least 3 day 'moderate ' severity heartburn previous 7 day No use acid suppression therapy ( PPI , H2RA , etc . ) within 14 day randomization A history gastric esophageal surgery H. pylori positive A history endoscopy verify erosive esophagitis within 16 week prior randomization Currently take high standard approve proton pump inhibitor dose Historical evidence number GI , cardiovascular , pulmonary , liver , kidney , pancreatic , cerebral vascular disease , organ transplant , condition require surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>